![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hebei Jianmin Starch Glucose Co., Ltd. Ningjin Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Oxytetracycline hydrochloride, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2013-200 - Rev 00
This Chemical Type CEP, issued on April 09, 2019, remains in force until November 09, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 198 associated with this CEP further emphasizes